Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts

Hude Quan1, Bing Li, Chantal M Couris

  • 1Department of Community Health Sciences, Faculty of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, Alberta, Canada T2N 4Z6. hquan@ucalgary.ca

Insights

The Charlson comorbidity index was updated to better predict mortality. This revised index, using 12 conditions, shows improved accuracy for in-hospital mortality prediction in recent international patient data.

Area of Science:

  • Health Services Research
  • Epidemiology
  • Biostatistics

Background:

  • The Charlson Comorbidity Index (CCI), developed in 1984, quantifies disease burden to predict mortality.
  • Advances in medical treatments and disease management may have altered the prognostic impact of comorbidities since the CCI's inception.

Purpose of the Study:

  • To reevaluate and update the CCI by reassessing comorbidity weights.
  • To assess the predictive performance of the updated CCI for in-hospital mortality using recent international data.

Main Methods:

  • Comorbidity weights were reassigned based on observed 1-year mortality after hospital discharge.
  • The updated index was applied to hospital discharge data from six countries (Australia, Canada, France, Japan, New Zealand, Switzerland).
  • The discriminative ability of the updated index was compared to the original CCI using C statistics for in-hospital mortality.

Main Results:

  • Updated weights varied significantly, with some comorbidities receiving zero weight, decreased weight, or increased weight compared to the original CCI.
  • The updated 12-comorbidity index demonstrated good-to-excellent discrimination for in-hospital mortality across all six countries.
  • C statistics for the updated index ranged from 0.727 to 0.878, generally performing comparably or slightly better than the original CCI.

Conclusions:

  • The updated Charlson comorbidity index shows strong predictive performance for in-hospital mortality.
  • The revised index may be more suitable for contemporary administrative datasets due to updated comorbidity weighting.
  • Revalidation of comorbidity indices is crucial to reflect evolving healthcare landscapes and treatment effectiveness.

Related Concept Videos

Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: